US Patent 7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease

Patent 7067515 was granted and assigned to Pfizer on June, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Pfizer

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

70675150

Patent Inventor Names

David W. Piotrowski0

Donn G. Wishka0

Steven Charles Reitz0

Vincent E. Groppi, Jr.0

Date of Patent

June 27, 2006

Patent Application Number

101635640

Date Filed

June 6, 2002

Patent Citations Received

‌

US Patent 12083114 Inhibitors of SARM1 in combination with neuro-protective agents

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The invention provides compounds of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API